CLINICAL_TRIALS
trial_result
· 2006-05-05
Clinical Trial Update: Dexanabinol in Severe Traumatic Brain Injury [Phase 3]
Summary
A Phase 3 trial evaluating dexanabinol for severe traumatic brain injury has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmos | Conditions: Traumatic Brain Injury | Phase 3 | Status: COMPLETED